Could ETQ's share price be soon to benefit from their developments with the new UVGI Nightingale Mobile Air Filtration Product.

New UVGI air filtration product

In November 2002, the ETQ announced its new Nightingale UVGI air filtration product, to be produced by a new joint-venture company, UVGI Systems Limited, owned 55% by the Group and 45% by Suvair Limited. This rapid response mobile air filtration unit is capable of killing the MRSA super bug and other airborne pathogens.

The UVGI unit has widespread application where there is need to keep
air free of dangerous live bacteria, viruses, and fungal spores, including
hospitals, schools, cruise liners, aircraft, food processing, and military
applications.

The UVGI unit uses a high intensity Ultra Violet Germicidal Irradiation ('UVGI')
filter, which has been designed to control harmful and dangerous airborne
pathogens, such as Anthrax, Tuberculosis, and Staphylococcus aureus, the
causative agent in MRSA. The filtration system is combined with use of high
intensity Ultra Violet light, which inactivates micro organisms by disrupting
their DNA structure.

Tests of a prototype at the Defence Science Technology Laboratory ('Dstl') at
Porton Down, the centre for excellence for the Ministry of Defence, showed that
the UVGI unit captured and/or destroyed more than 99.9% of Bacillus subtilis
spores, a simulant for Anthrax bacteria.

Since November, second generation units have been developed, which will go on
applications testing at an NHS Trust Hospital in December 2003, following
building completion of its new haematology unit. It is also anticipated the
UVGI unit will shortly go on laboratory testing in the United States with
contractors nominated by the Department of Homeland Security.

Concern seems to be hotting up on the T.V. news that the MRSA super bug is still killing and disabling people visiting or as patients in NH Trust hospitals. It would be surprising if NH Trust hospital do not notice and Buy this product before they get to many expensive law suits for compensation claims.

Definitely a stock that could soon be heading north. Worth buying in but DYOR

L.

RELATED NEWS LINKS

Sky News Sun 28th Sept 03 - NEW ANTIBIOTICS WARNING
BBC World News Thurs 4th December 03 - Hospital infections: Case studies
BBC World News Fri 5th Dec 03 - 'Superbug' crackdown is launched
BBC World News Monday 22nd Dec 03 - Superbugs lurk in intensive care
Sky News Sun 14th Dec 03 - SUPERBUG CARRIED BY PETS
BBC World News Thurs 26th Feb 04 - Superbug deaths increase 15-fold
BBC World News Mon 22nd March 04 - MRSA superbug hits more children
BBC World News Fri 2nd April 04 - Superbug outbreak in cardiac ward
BBC World News Thurs 8th April 04 - NHS faces superbug legal claims
BBC World News Sun 6th June 04 - Government 'complacent' over MRSA
BBC World News Fri 18th June 04 - Superbug deaths 'set to double'
BBC World News Thurs 1st July 04 - Holland's tough line combats MRSA
BBC World News Thurs 1st July 04 - Overcrowded hospitals breed MRSA
ITV.com Fri 9th July 04 - Mother's MRSA nightmare
ITV.com Fri 9th July 04 - 'MRSA superbug has done this to me'
ITV.com Fri 9th July 04 - Precautions you can take against MRSA
Sky News Sun 11th July 04 - WAR DECLARED ON MRSA
BBC UK News Mon 12th July 04 - Drive to fight hospital superbugs

I have just purchased 60,000 etq at 11.15 but they are shown as a sell, can someone tell me why they do this?

Shares are not reported as a trade or a sell. The MoneyAM algorithm calculates from the Bid and Offer if the transaction should go in the Sell or Buy pot, quite often the calculation is incorrect.

Rgerads

PTH

quiet thread lately




if 5 holds and it bounces up then there `may` (not a word I usually use) be a double bottom. Otherwise look to 4 to hold

Back to 4 & maybe below until the next piece of hype.

maybe is not a word I would use and I certainly wouldn`t hype. Just charting facts for me. ie a bounce off 5 is good depending on volume of course. There is a bullish tail on today`s candle so far (realtime charting system)

I have just been looking at candle volume. Candles which also show the volume in the candle and the candle today is very very thin ie it has moved on very small volume so the move today is pretty meaningless. I would not throw the baby out with the bathwater today

oops, I forgot, I did say that I wouldn`t post any more

bye all

please keep posting....

just in a measured way - thats all that was asked.

GN.

it was off 13% earlier down to 4, but seems to have recovered, temporary or not lets see.

Still not looking too good but you never know, there might be another temporary spike again soon.

yes but down heading for 4p

not necessarily momentum. We could be seeing consolidation ie a base forming.Daily Candle volume says that this downwards movement is happening on thin volume and weekly CV is simply range trading. Directional movement ADXR is in an obvious coil ie sideways. OK so 4 is too big a loss if you have 200k shares at 6 ish pence but the signs were there in the charts

if you believe in the company then this could be a speculative (if boring) buy

Some positive news on ADVFN...

BMW , is this wait you were referring to?

also With thanks to limescale on ample

who gave credit to

MBDRIVER over on ADVFN

http://www.thisishampshire.net/hampshire/archive/2004/09/17/BASINGSTOKE_NEWS_BUSINESS23ZM.html

full article below - not in particular the references to sales


First published on Friday 17 September 2004:


Nightingale joins fight to eradicate superbug


by Liz Woodford


A BASINGSTOKE company has developed an air filtration machine to kill the MRSA hospital superbug that claims thousands of lives each year.

But despite the breakthrough in technology, Energy Technique is finding sales in the UK tough going when faced with a National Health Service that is strapped for cash.

Only this month Leigh Stimpson, managing director of Energy Technique, who lives in Basingstoke, addressed a health commission in Ireland, which is looking into the superbug crisis.

The Irish meeting brought Mr Stimpson into contact with NHS chiefs and members of the public to get across the message that the Nightingale filtration unit has been shown to be 99.8 per cent effective by the Health Protection Agency at Porton Down in Wiltshire.

Mr Stimpson said: "This marked a welcome advance in our efforts to make contact with influential opinion-formers and decision-makers within the NHS."

He heads up a PLC group that has a 14million turnover a year and over the past four years has spent nearly 1million developing the Nightingale. Another 3million was raised in the city a few months ago for Energy Technique to forge ahead with its commercial development.

Nightingale uses ultraviolet radiation combined with sophisticated air-flow systems to attack the DNA of killer germs such as MRSA, anthrax and TB.

The units cost between 6,000 and 10,000 each and sales are starting to go well in America.

Now the American Defence Department is also showing interest which could result in an order of up to 500 units.

Mr Stimpson described the cost of a Nightingale unit as almost negligible compared with the cost of a life.

One unit cleanses the air in a ward of six beds, but he said it can only work effectively alongside properly-scrubbed wards and routine hand-washing by hospital staff and visitors.

Basingstoke hospital is to have some of the first Nightingale units in the country.

Mr Stimpson has donated three units and air conditioning worth 40,000 to the new oncology ward being partly-funded by the Elizabeth Hall Trust.

Mr Stimpson was full of praise for Basingstoke hospital chiefs.

He said: "They are taking the controlling of infection seriously."

Nightingale is manufactured at Energy Technique's factory in Surrey and distributed through a warehouse off Lister Road in Basingstoke.

The company has had a distribution centre in Basingstoke - where it employs 20 people - for three years. It expects the headcount to rise to 40 throughout the next year as it is doubling the size of its distribution operation on the same site.

As he fights to take Nightingale into more UK hospitals, Mr Stimpson said: "The growing threat of MRSA in our hospitals is an issue that affects everybody."

could anyone tell me if there are symptoms for MRSA?
if there are what are they.
thanks.

alderleyedge

It depends where in your body you get infected with it.

If you get it in a cut, it can kill you.

You could just get a sore throat.


Handwashing is the best defence against MRSA

The ETQ system is not really relavent to MRSA

Click here for BBC Programme info

Every time I have predicted that the downtrend on this share will continue it has. The downtrend is occasionally interupted by spikes because people don't understand MRSA or that this product is a way of levering their full scale aircon systems with UVGI into the market.

Mr Stimpson of ETQ is talking nonsense hype his product.
I think he is managing director but he sounds like a typical salesman to me.

cheers apple

Glad that you found it useful.

Apple

I am given to understand that a high percentage of dust is produced by discarded skin particles, so therefore if those particles are infected with MRSA then at some point those skin particles will be airborne. IMHO.

BMW You are clutching at straws.

If dead skin flakes are not dry then they stick to the body.
Discarded skin flakes are too dry to support MRSA so it won't survive long enough to have any significant probability of infecting a wound.

An unwashed hand can immediately transfer millions of bacteria to a wound.
A slightly sweaty hand can contaminate a doorhandle that may not dry out for an hour or so. Many people can then pick up millions of bacteria by touching that handle & then touch a patient.

Many people carry MRSA in their nose & throat without symptoms & don't sneeze until they get a cold as well.

When carriers touch their nose or mouth then they get MRSA on their hands & spread it.

UVGI will not help with handwashing.
UVGI will not stop people coughing or sneezing over a patient.


UVGI would be useful to stop airborne diseases spreading from 1 room to another, that is why the Nightingale product is mainly a technology demonstrator that may leverage ETQ into contracts for whole building aircon systems with UVGI technology.

The Nightingale product could be used to isolate people in a plastic tent where nurses work on them from the outside but I don't think that happens very often.

To prevent MRSA, wash your hands & clean the urine etc from the floor, beds etc.
Clean all surfaces because people keep touching them.